Mometasone furoate
| CAS No. | 83919-23-7 | Cat. No. | BCP06569 |
| Name | Mometasone furoate | ||
| Synonyms | Elocon;Nasonex;Sch32088;Twisthaler; | ||
| Formula | C32H32Cl2O8 | M. Wt | 615.5 |
| Description | Mometasone furoate is used in the treatment of inflammatory skin disorders (such as eczema and psoriasis), allergic rhinitis (such as hay fever), asthma. MF is approved for once or bid maintenance treatment of asthma (in patients previously receiving ICS or bronchodilators). Low systemic bioavailability and high relative binding affinity for the glucocorticoid receptor are properties of MF that allow for a favourable efficacy and tolerability profile. Inhaled MF has been shown to be an effective and well-tolerated controller medication for those patients with mild, moderate or severe persistent asthma . | ||
| Pathways | GPCR/G Protein | ||
| Targets | Glucocorticoid Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.